Skip to main content

Hepatitis a adult vaccine Disease Interactions

There are 3 disease interactions with hepatitis a adult vaccine.

Moderate

Hepatitis A adult vaccine (applies to hepatitis a adult vaccine) liver disease

Moderate Potential Hazard, Moderate plausibility.

The use of hepatitis A adult vaccine in patients with chronic liver disease may have lower antibody response to the vaccine. Monitoring is recommended when vaccinating these patients.

References

  1. "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham
Moderate

Hepatitis A vaccine (applies to hepatitis a adult vaccine) immunocompromised

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency

The use of hepatitis A vaccine in immunocompromised persons, including individuals receiving immunosuppressive therapy, may result in diminished immune response to the vaccine and these patients may not be protected against hepatitis A virus. Monitoring is recommended when vaccinating these patients.

References

  1. "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham
  2. (2022) "Product Information. Vaqta (hepatitis A adult vaccine)." Merck & Co., Inc
Moderate

Hepatitis A vaccine (applies to hepatitis a adult vaccine) liver dysfunction

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

The use of hepatitis A vaccine in patients with chronic liver disease may result in lower antibody response. Care should be exercised when using this agent in patients with liver disease.

References

  1. "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham

Hepatitis a adult vaccine drug interactions

There are 288 drug interactions with hepatitis a adult vaccine.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer